Who Should Be Considered for Islet Transplantation Alone?

被引:8
|
作者
Othonos, Nantia [1 ]
Choudhary, Pratik [1 ]
机构
[1] Kings Coll London, Dept Diabet, Denmark Hill, London SE5 9RJ, England
关键词
Type; 1; diabetes; Islet cell transplantation; Hypoglycemia; Impairedawareness ofhypoglycemia; Severe hypoglycemia; Transplantation; INSULIN-PUMP THERAPY; SEVERE HYPOGLYCEMIA; NOCTURNAL HYPOGLYCEMIA; IMPAIRED AWARENESS; TYPE-1; ADULTS; FREQUENCY; TRIAL; INJECTIONS; SUSPENSION;
D O I
10.1007/s11892-017-0847-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of Review Episodic hypoglycemia is an almost inevitable consequence of exogenous insulin treatment of type 1 diabetes, and in up to 30% of patients, this can lead to impaired awareness of hypoglycemia. This predisposes to recurrent severe hypoglycemia and has a huge impact on quality of life. Although many patients can get resolution of severe hypoglycemia through novel education and technology, some patients continue to have ongoing life-threatening hypoglycemia. Islet transplantation offers an alternative therapeutic option for these patients, in whom these conventional approaches have been unsuccessful. This review discusses the selection process of identifying suitable candidates based on recent clinical data. Recent Findings Results from studies of islet transplantation suggest the optimal recipient characteristics for successful islet transplantation include age > 35 years, insulin requirements < 1.0/kg, and weight > 85 kg. Summary Islet transplantation can completely resolve hypoglycemia and near-normalize glucose levels, achieving insulin independence for a limited period of time in up to 40% of patients. The selection of appropriate candidates, optimizing donor selection, the use of an optimized protocol for islet cell extraction, and immunosuppression therapy have been proved to be the key criteria for a favorable outcome in islet transplantation.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Liver transplantation - Who should be referred - and when?
    Luxon, BA
    POSTGRADUATE MEDICINE, 1997, 102 (06) : 103 - +
  • [42] Islet transplantation alone in type 1 diabetes: Single center experience
    Maffi, P
    Bertuzzi, F
    De Taddeo, F
    Nano, R
    Venturini, M
    Del Maschio, A
    Secchi, A
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 377 - 377
  • [43] Platelet indices should not be considered a stand-alone test for monitoring the disease progression
    Yalcinkaya, E.
    Celik, M.
    Bugan, B.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2013, 17 (19) : 2693 - 2693
  • [44] Islet transplantation improves vascular diabetic complications in patients with diabetes who underwent kidney transplantation: A comparison between kidney-pancreas and kidney-alone transplantation.
    Fiorina, P
    Folli, F
    Maffi, P
    Placidi, C
    Venturini, M
    Finzi, G
    Bertuzzi, F
    Davalli, A
    D'Angelo, A
    Socci, C
    Gremizzi, C
    Orsenigo, E
    la Rosa, S
    Ponzoni, M
    Cardillo, M
    Scalamogna, M
    del Maschio, A
    Capella, C
    di Carlo, V
    Secchi, A
    TRANSPLANTATION, 2003, 75 (08) : 1296 - 1301
  • [45] Islet with kidney versus islet transplantation alone: Clinical experience in patients with type 1 diabetes.
    Maffi, Paola
    De Taddeo, Francesca
    Bertuzzi, Federico
    Nano, Rita
    Melzi, Raffaella
    Socci, Carlo
    Venturini, Massimo
    Del Maschio, Alessandro
    Piemonti, Lorenzo
    Secchi, Antonio
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 571 - 572
  • [46] MAGNETIC RESONANCE IMAGING ALONE SHOULD NOT BE CONSIDERED AS A STAND-ALONE TEST FOR DISEASE RECLASSIFICATION OF MEN IN ACTIVE SURVEILLANCE
    Roscigno, Marco
    Stabile, Armando
    Lughezzani, Giovanni
    La Croce, Giovanni
    Pepe, Pietro
    Nicolai, Maria
    Galosi, Andrea
    Naselli, Angelo
    Balzarini, Luca
    Sironi, Sandro
    Guazzoni, Giorgio
    Briganti, Alberto
    Montorsi, Francesco
    Da Pozzo, Luigi Filippo
    ANTICANCER RESEARCH, 2019, 39 (03) : 1558 - 1559
  • [48] Islet transplantation for type 1 diabetes—where should we go?
    Piotr Witkowski
    Kevan C Herold
    Nature Clinical Practice Endocrinology & Metabolism, 2007, 3 : 2 - 3
  • [49] Islet transplantation for type 1 diabetes - where should we go?
    Witkowski, Piotr
    Herold, Kevan C.
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2007, 3 (01): : 2 - 3
  • [50] Should posttransplant cyclophosphamide be considered standard of care for pediatric transplantation of acute leukemia?
    Doherty, Erin E.
    Krance, Robert A.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2023, (01) : 171 - 174